AGP Executive Report
Last update: 27 minutes agoAI Chip Controls: The U.S. has moved to require approval before overseas data centers can provide advanced American AI computing power to Chinese firms, closing a cloud-access route and widening licensing rules across several countries. Supercomputing: China’s LineShine retained the top spot in the latest Top500 ranking, delivering 2.198 exaflops on the benchmark without accelerators, as AI data centers absorb much of the new computing hardware. Electric Aviation: COMAC’s 19-seat CE-25A completed its first piloted flight in Shandong; China’s aviation regulator has accepted its application for type certification, a step toward commercial service. Biotech: The U.S. FDA declined to approve China-developed lung cancer drug ivonescimab, saying trial results did not establish a significant overall-survival benefit. Industry: China’s high-tech manufacturing helped drive industrial growth in January–October, even as October factory output and retail sales came in below forecasts.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.